Sabra Health Care REIT (SBRA)
Market Price (3/28/2026): $19.605 | Market Cap: $4.9 BilSector: Real Estate | Industry: Health Care REITs
Sabra Health Care REIT (SBRA)
Market Price (3/28/2026): $19.605Market Cap: $4.9 BilSector: Real EstateIndustry: Health Care REITs
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.1%, Dividend Yield is 5.9%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.1%, FCF Yield is 7.1% | Meaningful short interestShort Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 11.28, Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 11% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 51% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 45%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 45% | Key risksSBRA key risks include [1] significant tenant concentration, Show more. | |
| Low stock price volatilityVol 12M is 21% | ||
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.1%, Dividend Yield is 5.9%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.1%, FCF Yield is 7.1% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 45%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 45% |
| Low stock price volatilityVol 12M is 21% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care. |
| Meaningful short interestShort Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 11.28, Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 11% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 51% |
| Key risksSBRA key risks include [1] significant tenant concentration, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Sabra Health Care REIT (SBRA) stock has remained largely at the same level since 11/30/2025 because of the following key factors:
1. Sabra Health Care REIT issued positive 2026 earnings guidance, projecting an approximate 5% year-over-year increase in normalized Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO), despite missing fourth-quarter 2025 EPS estimates of $0.37 with a reported $0.11.
2. The company maintained a consistent quarterly cash dividend of $0.30 per share, declared on February 2, 2026, representing an annualized dividend of $1.20 and an approximate 5.8% yield, which reinforced investor confidence in shareholder returns.
Show more
1. Sabra Health Care REIT issued positive 2026 earnings guidance, projecting an approximate 5% year-over-year increase in normalized Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO), despite missing fourth-quarter 2025 EPS estimates of $0.37 with a reported $0.11.
2. The company maintained a consistent quarterly cash dividend of $0.30 per share, declared on February 2, 2026, representing an annualized dividend of $1.20 and an approximate 5.8% yield, which reinforced investor confidence in shareholder returns.
Show more
Stock Movement Drivers
Fundamental Drivers
The 2.0% change in SBRA stock from 11/30/2025 to 3/27/2026 was primarily driven by a 19.4% change in the company's P/E Multiple.| (LTM values as of) | 11302025 | 3272026 | Change |
|---|---|---|---|
| Stock Price ($) | 19.22 | 19.61 | 2.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 745 | 775 | 4.0% |
| Net Income Margin (%) | 23.5% | 20.1% | -14.5% |
| P/E Multiple | 26.3 | 31.4 | 19.4% |
| Shares Outstanding (Mil) | 240 | 249 | -3.8% |
| Cumulative Contribution | 2.0% |
Market Drivers
11/30/2025 to 3/27/2026| Return | Correlation | |
|---|---|---|
| SBRA | 2.0% | |
| Market (SPY) | -5.3% | -13.6% |
| Sector (XLRE) | -2.9% | 26.6% |
Fundamental Drivers
The 5.9% change in SBRA stock from 8/31/2025 to 3/27/2026 was primarily driven by a 30.0% change in the company's P/E Multiple.| (LTM values as of) | 8312025 | 3272026 | Change |
|---|---|---|---|
| Stock Price ($) | 18.52 | 19.61 | 5.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 733 | 775 | 5.7% |
| Net Income Margin (%) | 24.9% | 20.1% | -19.2% |
| P/E Multiple | 24.2 | 31.4 | 30.0% |
| Shares Outstanding (Mil) | 238 | 249 | -4.6% |
| Cumulative Contribution | 5.9% |
Market Drivers
8/31/2025 to 3/27/2026| Return | Correlation | |
|---|---|---|
| SBRA | 5.9% | |
| Market (SPY) | 0.6% | -6.7% |
| Sector (XLRE) | -3.7% | 38.1% |
Fundamental Drivers
The 25.9% change in SBRA stock from 2/28/2025 to 3/27/2026 was primarily driven by a 11.5% change in the company's Net Income Margin (%).| (LTM values as of) | 2282025 | 3272026 | Change |
|---|---|---|---|
| Stock Price ($) | 15.57 | 19.61 | 25.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 703 | 775 | 10.2% |
| Net Income Margin (%) | 18.0% | 20.1% | 11.5% |
| P/E Multiple | 29.1 | 31.4 | 8.1% |
| Shares Outstanding (Mil) | 237 | 249 | -5.1% |
| Cumulative Contribution | 25.9% |
Market Drivers
2/28/2025 to 3/27/2026| Return | Correlation | |
|---|---|---|
| SBRA | 25.9% | |
| Market (SPY) | 9.8% | 6.2% |
| Sector (XLRE) | -4.1% | 41.8% |
Fundamental Drivers
The 107.7% change in SBRA stock from 2/28/2023 to 3/27/2026 was primarily driven by a 81.0% change in the company's P/S Multiple.| (LTM values as of) | 2282023 | 3272026 | Change |
|---|---|---|---|
| Stock Price ($) | 9.44 | 19.61 | 107.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 625 | 775 | 24.0% |
| P/S Multiple | 3.5 | 6.3 | 81.0% |
| Shares Outstanding (Mil) | 231 | 249 | -7.4% |
| Cumulative Contribution | 107.7% |
Market Drivers
2/28/2023 to 3/27/2026| Return | Correlation | |
|---|---|---|
| SBRA | 107.7% | |
| Market (SPY) | 69.4% | 20.9% |
| Sector (XLRE) | 16.1% | 52.5% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| SBRA Return | -16% | 0% | 26% | 31% | 17% | 5% | 72% |
| Peers Return | 6% | -9% | 24% | 31% | 33% | 5% | 120% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -5% | 72% |
Monthly Win Rates [3] | |||||||
| SBRA Win Rate | 50% | 50% | 50% | 67% | 50% | 33% | |
| Peers Win Rate | 53% | 50% | 62% | 70% | 60% | 60% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| SBRA Max Drawdown | -23% | -12% | -16% | -10% | -7% | -4% | |
| Peers Max Drawdown | -12% | -22% | -5% | -9% | -4% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -5% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: WELL, VTR, OHI, NHI, CTRE.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/27/2026 (YTD)
How Low Can It Go
| Event | SBRA | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -45.7% | -25.4% |
| % Gain to Breakeven | 84.0% | 34.1% |
| Time to Breakeven | 543 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -73.5% | -33.9% |
| % Gain to Breakeven | 277.5% | 51.3% |
| Time to Breakeven | Not Fully Recovered days | 148 days |
| 2018 Correction | ||
| % Loss | -44.7% | -19.8% |
| % Gain to Breakeven | 80.9% | 24.7% |
| Time to Breakeven | Not Fully Recovered days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -59.3% | -56.8% |
| % Gain to Breakeven | 145.6% | 131.3% |
| Time to Breakeven | Not Fully Recovered days | 1,480 days |
Compare to WELL, VTR, OHI, NHI, CTRE
In The Past
Sabra Health Care REIT's stock fell -45.7% during the 2022 Inflation Shock from a high on 7/29/2021. A -45.7% loss requires a 84.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Sabra Health Care REIT (SBRA)
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
AI Analysis | Feedback
1. The Simon Property Group for healthcare facilities.
2. Prologis for hospitals and senior living communities.
3. A hotel REIT like Host Hotels & Resorts, but for healthcare facilities.
AI Analysis | Feedback
- Skilled Nursing and Transitional Care Facilities: Sabra leases real estate properties specifically designed for skilled nursing and transitional care services.
- Senior Housing Communities (Leased): Sabra leases its senior housing real estate properties to third-party operators.
- Senior Housing Communities (Managed): Sabra owns senior housing properties that are operated by third-party property managers.
- Specialty Hospitals and Other Facilities: Sabra leases various other healthcare-related real estate properties, including specialty hospitals.
- Real Estate-Backed Loans: Sabra provides financing through mortgage loans, construction loans, and other loans secured by real estate.
- Preferred Equity Investments: Sabra makes preferred equity investments in entities involved in healthcare real estate.
- Direct Financing Leases: Sabra offers financing through direct financing lease arrangements for healthcare properties.
AI Analysis | Feedback
Major Customers of Sabra Health Care REIT (SBRA)
Sabra Health Care REIT (SBRA) is a real estate investment trust that primarily leases and finances healthcare properties. Therefore, its major customers are other companies that operate these facilities or are the recipients of Sabra's financial investments, rather than individuals.
Based on the provided information, Sabra's major customer categories are:
- Companies that operate Skilled Nursing/Transitional Care facilities under lease agreements with Sabra.
- Companies that operate Senior Housing communities, either leasing the properties directly from Sabra ("Senior Housing - Leased") or managing properties for Sabra ("Senior Housing - Managed").
- Companies that operate Specialty Hospitals and Other facilities under lease agreements with Sabra.
- Companies that are borrowers for Sabra's various loans receivable (mortgage, construction, and other loans) or recipients of preferred equity investments.
The provided background information does not list the specific names of these operating companies or borrowers, nor does it indicate if any are public companies with associated symbols.
AI Analysis | Feedback
- Enlivant
- Atria Senior Living
AI Analysis | Feedback
Richard K. Matros, Chairman of the Board, President and Chief Executive Officer
Richard K. Matros has served as Sabra's President and Chief Executive Officer since May 2010, and as Chairman of the Board since November 2010. Before Sabra, he was Chairman of the Board and Chief Executive Officer of Sun Healthcare Group, Inc. from 2001 until Sabra's inception in November 2010, successfully leading Sun Healthcare out of bankruptcy in 2002. Mr. Matros founded and served as Chief Executive Officer and President of Bright Now! Dental from 1998 to 2000, continuing as a Director until its sale in December 2010. His extensive experience in long-term care includes senior roles at Regency Health Services, Inc. and Care Enterprises, Inc. He was also involved with CareMeridian, LLC, and is the Executive Producer of Sabra Films, LLC. In 2023, he co-executive produced "Legacy: The True Story of the LA Lakers," which earned an Emmy in the Sports Documentary category.
Michael L. Costa, Executive Vice President, Chief Financial Officer and Treasurer
Michael L. Costa has served as Sabra's Chief Financial Officer since January 2022. His career at Sabra began at the company's inception in 2010 as Controller, and he progressively advanced through roles including Vice President – Finance and Controller, Executive Vice President – Finance, and Chief Accounting Officer. Mr. Costa possesses over 20 years of experience in commercial real estate finance and accounting, with prior experience at KBS Realty Advisors and Ernst & Young's Real Estate Assurance practice. He is a Certified Public Accountant (inactive) and a licensed California real estate broker.
Darrin Smith, Chief Investment Officer, Secretary and Executive Vice President
Darrin Smith was appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. He joined Sabra in March 2020, serving as Executive Vice President, Investments prior to his current role. Earlier in his career, he held senior leadership positions at HCP, Inc. (now Healthpeak Properties, Inc.), a healthcare REIT, from 2005 to 2018, where he was Senior Vice President-Senior Housing Investments. He also gained six years of experience in acquisitions and portfolio management at GE Capital Real Estate, reaching the position of Senior Director of Portfolio Management. Mr. Smith also spent over five years in the real estate group of Ernst & Young, LLP. He is a Certified Public Accountant (inactive status).
Peter Nyland, Executive Vice President, Asset Management
Peter Nyland has been with Sabra since January 2013, serving as Executive Vice President, Asset Management. Before joining Sabra, he held roles at Sun Healthcare Group as Senior Vice President Purchasing, Asset Development and Real Estate, and as President of its subsidiary, Americare Health Services, starting in 2002. From 1983 to 2002, Mr. Nyland accumulated experience at Beverly Enterprises in various senior-level capacities, including Vice President of Strategic Development.
AI Analysis | Feedback
Here are the key risks to Sabra Health Care REIT (SBRA):
- Increased Operational Risks from Senior Housing Operating Portfolio (SHOP) Exposure: Sabra's strategic initiative to increase its exposure to Senior Housing Operating Portfolio (SHOP) assets, while presenting growth opportunities, introduces additional operational risks. SHOP assets are more susceptible to market fluctuations and necessitate more hands-on management compared to triple-net leased properties. This heightened exposure could lead to greater volatility in Sabra's earnings and cash flows, especially if economic conditions or senior housing market dynamics shift unfavorably. The company also faces challenges from unpredictable operator performance, with some operators struggling to meet rent obligations in an inflationary cost environment.
- Sector Concentration and Regulatory/Reimbursement Risks: Sabra's significant concentration in healthcare properties, particularly skilled nursing and senior housing, makes it vulnerable to industry-specific downturns. Changes in healthcare regulations, including those affecting Medicare and Medicaid reimbursement rates, could disproportionately impact Sabra's financial performance and the stability of its revenue streams.
- Interest Rate Fluctuations and Debt Levels: An increase in market interest rates poses a significant risk as it could raise Sabra's interest costs on borrowings under its revolving credit facility and any future debt. Rising interest rates could also limit the company's ability to refinance existing debt when it matures or result in higher interest rates upon refinancing. Sabra's significant debt obligations are also identified as a weakness that could constrain its financial flexibility.
AI Analysis | Feedback
The clear emerging threat for Sabra Health Care REIT is the accelerating shift towards home-based care models and the increased adoption of telehealth and remote patient monitoring technologies. These advancements enable care to be delivered more effectively and conveniently in a patient's home, potentially reducing the demand for and length of stays in facility-based settings like skilled nursing facilities and senior housing communities, which constitute a significant portion of Sabra's investment portfolio.
AI Analysis | Feedback
Sabra Health Care REIT (symbol: SBRA) operates in the healthcare real estate sector, primarily focusing on skilled nursing/transitional care facilities and senior housing communities in the United States and Canada.
Addressable Markets for Main Products/Services:
- Skilled Nursing Facilities (U.S.): The U.S. market for skilled nursing facilities is estimated to be approximately USD 202.4 billion in 2025. This market is anticipated to grow to USD 279.9 billion by 2035, at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2035. Other estimates place the market size at USD 199.72 billion in 2024, expected to reach USD 205.62 billion in 2025, and USD 290.02 billion by 2033, growing at a CAGR of 4.39% from 2025 to 2033.
- Senior Housing (U.S.): The U.S. senior living market size was valued at USD 943.90 billion in 2025 and is projected to reach USD 1.33 trillion by 2033, demonstrating a CAGR of 4.47% from 2026 to 2033. Another source valued the U.S. senior living market at USD 923.20 billion in 2023, with a projection to reach approximately USD 1.22 trillion by 2030, growing at a CAGR of 4.16%.
- Nursing Care Facilities (Canada): The market size of Nursing Care Facilities in Canada was USD 10.3 billion in 2024 and is projected to reach USD 10.6 billion in 2025. This market experienced a CAGR of 2.6% between 2020 and 2025.
- Long-Term Care (Canada) - including Senior Housing/Assisted Living: The broader Canada long-term care market, which includes nursing care, hospice, and assisted living facilities, generated a revenue of USD 29,123.0 million (approximately USD 29.1 billion) in 2023. It is expected to grow to USD 41,876.4 million by 2030, at a CAGR of 5.2% from 2024 to 2030. While specific standalone market sizes for "Senior Housing" in Canada vary significantly across different reports, this long-term care market provides a more comprehensive overview of services relevant to Sabra's Canadian senior-focused portfolio.
- Specialty Hospitals and Other facilities: Null
AI Analysis | Feedback
Expected Drivers of Future Revenue Growth for Sabra Health Care REIT (SBRA)
- Strong Performance and Expansion of the Senior Housing Operating Portfolio (SHOP): Sabra's managed senior housing portfolio has demonstrated robust growth, with sequential revenue growth of 15.8% and cash Net Operating Income (NOI) growth of 18.4% in Q4 2025. The company's same-store managed senior housing saw revenue increase by 6.4% year-over-year in Q4 2025, and occupancy rose by 160 basis points to 87.9%. Management anticipates low to mid-teens NOI growth for its SHOP portfolio in 2026. Sabra is also strategically increasing its target for the SHOP portfolio to 40% of its total assets, highlighting its focus on this segment for significant future growth.
- Favorable Demographic Trends and Supply Constraints: The aging population serves as a significant tailwind for Sabra. The population aged 80 and older is projected to grow by 4% annually through 2040, driving sustained demand for senior care services. Concurrently, there is a persistent constraint on new supply for both senior housing and skilled nursing facilities. This widening gap between increasing demand and limited supply supports sustained occupancy strength and pricing power across Sabra's portfolio.
- Strategic Acquisitions and Robust Investment Pipeline: Sabra is actively pursuing growth through strategic acquisitions, particularly in the senior housing sector. The company completed approximately $450 million in investments for 2025 and expects to materially exceed that volume in 2026, with $240 million in awarded deals already progressing. The acquisition pipeline remains robust and is heavily weighted toward SHOP assets, indicating a continued focus on expanding this high-growth segment of its portfolio.
- Occupancy Recovery and Enhanced Pricing Power: Sabra anticipates continued occupancy improvements across its properties, including both its managed senior housing and skilled nursing portfolios. In Q4 2025, RevPOR (revenue per occupied room) for the same-store managed senior housing portfolio increased by 4.2% year-over-year. Management expects the U.S. portfolio to reach low-to-mid 90s occupancy over time, which will further enhance pricing power and contribute to organic revenue growth. This operational momentum is expected to result in low single-digit cash NOI growth for the triple-net portfolio and low to mid-teens growth for the same-store senior housing managed portfolio in 2026.
AI Analysis | Feedback
Share Issuance
- In the fourth quarter of 2025, Sabra issued 2.3 million shares, settling outstanding forward sale agreements, which resulted in net proceeds of $40.0 million.
- As of December 31, 2025, 17.4 million shares remained outstanding under forward sale agreements at a weighted average price of $18.60 per share.
- Sabra's shares outstanding increased from 0.233 billion in 2023 to 0.244 billion in 2025.
Outbound Investments
- Sabra completed approximately $450 million in investments during 2025, with an estimated average initial cash yield of 7.5% on property acquisitions, primarily focused on managed senior housing.
- In the fourth quarter of 2025, Sabra acquired four managed senior housing properties for $150.5 million.
- The company anticipates materially exceeding its 2025 investment volume in 2026, with an additional $240 million of primarily managed senior housing and some skilled nursing investments expected to close in Q1 and early Q2 2026.
- During the fourth quarter of 2025, Sabra disposed of seven skilled nursing facilities for gross proceeds of $51.0 million.
Capital Expenditures
- Normalized FFO and Normalized AFFO calculations by Sabra do not consider the costs associated with capital expenditures related to the company's real estate assets.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to SBRA.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02272026 | KRC | Kilroy Realty | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02202026 | AAT | American Assets Trust | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | -0.2% | -0.2% | -1.5% |
| 12122025 | LINE | Lineage | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 11.7% | 11.7% | -7.3% |
| 11302025 | OHI | Omega Healthcare Investors | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 6.7% | 6.7% | -6.0% |
| 10312025 | ADC | Agree Realty | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 11.8% | 11.8% | -2.8% |
| 06302020 | SBRA | Sabra Health Care REIT | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 26.0% | 35.7% | -7.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 63.22 |
| Mkt Cap | 10.7 |
| Rev LTM | 982 |
| Op Inc LTM | 310 |
| FCF LTM | 629 |
| FCF 3Y Avg | 527 |
| CFO LTM | 636 |
| CFO 3Y Avg | 534 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 15.8% |
| Rev Chg 3Y Avg | 11.5% |
| Rev Chg Q | 22.5% |
| QoQ Delta Rev Chg LTM | 5.3% |
| Op Mgn LTM | 42.4% |
| Op Mgn 3Y Avg | 44.6% |
| QoQ Delta Op Mgn LTM | -0.9% |
| CFO/Rev LTM | 54.0% |
| CFO/Rev 3Y Avg | 53.0% |
| FCF/Rev LTM | 54.0% |
| FCF/Rev 3Y Avg | 52.6% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 10.7 |
| P/S | 10.8 |
| P/EBIT | 21.3 |
| P/E | 29.5 |
| P/CFO | 18.8 |
| Total Yield | 6.8% |
| Dividend Yield | 3.3% |
| FCF Yield 3Y Avg | 5.9% |
| D/E | 0.3 |
| Net D/E | 0.3 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -6.1% |
| 3M Rtn | 4.0% |
| 6M Rtn | 9.3% |
| 12M Rtn | 25.4% |
| 3Y Rtn | 118.8% |
| 1M Excs Rtn | 1.6% |
| 3M Excs Rtn | 12.2% |
| 6M Excs Rtn | 13.9% |
| 12M Excs Rtn | 13.3% |
| 3Y Excs Rtn | 64.5% |
Price Behavior
Price Behavior
| Market Price | $19.61 | |
| Market Cap ($ Bil) | 4.9 | |
| First Trading Date | 04/02/2002 | |
| Distance from 52W High | -6.2% | |
| 50 Days | 200 Days | |
| DMA Price | $19.69 | $18.46 |
| DMA Trend | up | up |
| Distance from DMA | -0.4% | 6.2% |
| 3M | 1YR | |
| Volatility | 21.7% | 20.8% |
| Downside Capture | -0.27 | -0.16 |
| Upside Capture | -22.57 | 0.26 |
| Correlation (SPY) | -9.1% | 5.6% |
SBRA Betas & Captures as of 2/28/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -1.08 | -0.71 | -0.71 | -0.30 | 0.05 | 0.31 |
| Up Beta | 0.39 | 0.37 | 0.17 | 0.72 | 0.31 | 0.32 |
| Down Beta | -2.13 | -0.91 | -0.97 | -0.54 | -0.06 | 0.24 |
| Up Capture | -39% | -45% | -52% | -20% | 2% | 18% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 15 | 23 | 32 | 64 | 133 | 406 |
| Down Capture | -226% | -156% | -122% | -83% | -51% | 45% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 6 | 18 | 28 | 59 | 116 | 338 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SBRA | |
|---|---|---|---|---|
| SBRA | 21.3% | 20.8% | 0.83 | - |
| Sector ETF (XLRE) | -1.0% | 16.3% | -0.24 | 40.6% |
| Equity (SPY) | 14.5% | 18.9% | 0.59 | 5.5% |
| Gold (GLD) | 50.2% | 27.7% | 1.46 | 12.4% |
| Commodities (DBC) | 17.8% | 17.6% | 0.85 | 3.1% |
| Real Estate (VNQ) | 0.4% | 16.4% | -0.15 | 39.9% |
| Bitcoin (BTCUSD) | -21.0% | 44.0% | -0.41 | -1.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SBRA | |
|---|---|---|---|---|
| SBRA | 10.4% | 26.9% | 0.37 | - |
| Sector ETF (XLRE) | 3.9% | 19.0% | 0.11 | 51.3% |
| Equity (SPY) | 11.8% | 17.0% | 0.54 | 32.1% |
| Gold (GLD) | 20.7% | 17.7% | 0.96 | 10.8% |
| Commodities (DBC) | 11.6% | 18.9% | 0.50 | 10.3% |
| Real Estate (VNQ) | 3.0% | 18.8% | 0.07 | 54.5% |
| Bitcoin (BTCUSD) | 4.7% | 56.6% | 0.30 | 12.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SBRA | |
|---|---|---|---|---|
| SBRA | 8.1% | 36.5% | 0.32 | - |
| Sector ETF (XLRE) | 5.9% | 20.4% | 0.25 | 59.2% |
| Equity (SPY) | 14.0% | 17.9% | 0.67 | 43.8% |
| Gold (GLD) | 13.3% | 15.8% | 0.70 | 7.7% |
| Commodities (DBC) | 8.2% | 17.6% | 0.39 | 20.7% |
| Real Estate (VNQ) | 4.7% | 20.7% | 0.19 | 65.4% |
| Bitcoin (BTCUSD) | 66.9% | 66.8% | 1.06 | 14.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/12/2026 | -0.4% | -1.6% | 3.3% |
| 11/5/2025 | 3.6% | 3.7% | 7.4% |
| 8/4/2025 | -1.2% | 1.2% | 4.9% |
| 5/5/2025 | 3.5% | 3.6% | 3.8% |
| 2/19/2025 | -1.0% | -1.0% | 4.7% |
| 10/31/2024 | -3.9% | -0.4% | -3.7% |
| 8/7/2024 | -1.2% | -1.4% | 5.5% |
| 5/8/2024 | -2.6% | -2.4% | -3.9% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 5 | 10 | 16 |
| # Negative | 19 | 14 | 8 |
| Median Positive | 3.5% | 2.6% | 4.7% |
| Median Negative | -1.4% | -1.8% | -4.5% |
| Max Positive | 8.5% | 11.9% | 46.5% |
| Max Negative | -13.3% | -8.0% | -18.4% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/12/2026 | 10-K |
| 09/30/2025 | 11/05/2025 | 10-Q |
| 06/30/2025 | 08/04/2025 | 10-Q |
| 03/31/2025 | 05/05/2025 | 10-Q |
| 12/31/2024 | 02/19/2025 | 10-K |
| 09/30/2024 | 10/31/2024 | 10-Q |
| 06/30/2024 | 08/07/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 02/27/2024 | 10-K |
| 09/30/2023 | 11/06/2023 | 10-Q |
| 06/30/2023 | 08/07/2023 | 10-Q |
| 03/31/2023 | 05/03/2023 | 10-Q |
| 12/31/2022 | 02/21/2023 | 10-K |
| 09/30/2022 | 11/07/2022 | 10-Q |
| 06/30/2022 | 08/03/2022 | 10-Q |
| 03/31/2022 | 05/04/2022 | 10-Q |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.